Literature DB >> 22819494

Synthetic biology advancing clinical applications.

Marc Folcher1, Martin Fussenegger.   

Abstract

The 'omics' era, with its identification of genetic and protein components, has combined with systems biology, which provided insights into network structures, to set the stage for synthetic biology, an emerging interdisciplinary life science that uses engineering principles. By capitalizing on an iterative design cycle that involves molecular and computational biology tools to assemble functional designer devices from a comprehensive catalogue of standardized biological components with predictable functions, synthetic biology has significantly advanced our understanding of complex control dynamics that program living systems. Such insights, collected over the past decade, are priming a variety of synthetic biology-inspired biomedical applications that have the potential to revolutionize drug discovery and production technologies, as well as treatment strategies for infectious diseases and metabolic disorders.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22819494     DOI: 10.1016/j.cbpa.2012.06.008

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  15 in total

1.  Rethinking risk assessment for emerging technology first-in-human trials.

Authors:  Anna Genske; Sabrina Engel-Glatter
Journal:  Med Health Care Philos       Date:  2016-03

Review 2.  Building synthetic memory.

Authors:  Mara C Inniss; Pamela A Silver
Journal:  Curr Biol       Date:  2013-09-09       Impact factor: 10.834

3.  Optogenerapy: When bio-electronic implant enters the modern syringe era.

Authors:  Fanny Michel; Marc Folcher
Journal:  Porto Biomed J       Date:  2017-07-29

4.  Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.

Authors:  Junhao Lin; Yuchen Liu; Yonghao Zhan; Chengle Zhuang; Li Liu; Xing Fu; Wen Xu; Jianfa Li; Mingwei Chen; Zhiming Cai; Weiren Huang
Journal:  Tumour Biol       Date:  2015-10-01

5.  Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.

Authors:  Mitchell S Weisenberger; Tara L Deans
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-19       Impact factor: 3.346

Review 6.  Synthetic biology in mammalian cells: next generation research tools and therapeutics.

Authors:  Florian Lienert; Jason J Lohmueller; Abhishek Garg; Pamela A Silver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01-17       Impact factor: 94.444

7.  Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.

Authors:  Jason S Park; Benjamin Rhau; Aynur Hermann; Krista A McNally; Carmen Zhou; Delquin Gong; Orion D Weiner; Bruce R Conklin; James Onuffer; Wendell A Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

8.  A platform for rapid prototyping of synthetic gene networks in mammalian cells.

Authors:  Xavier Duportet; Liliana Wroblewska; Patrick Guye; Yinqing Li; Justin Eyquem; Julianne Rieders; Tharathorn Rimchala; Gregory Batt; Ron Weiss
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

9.  Synthetic mammalian trigger-controlled bipartite transcription factors.

Authors:  Marc Folcher; Mingqi Xie; Andrea Spinnler; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2013-05-17       Impact factor: 16.971

Review 10.  Biomedically relevant circuit-design strategies in mammalian synthetic biology.

Authors:  William Bacchus; Dominique Aubel; Martin Fussenegger
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.